SCOPUS 정보 검색 플랫폼

American Journal of Medical Genetics, Part A

Volumn 155, Issue 7, 2011, Pages 1721-1722

Neurofibromatosis 2: A novel risk factor for hypertension?

(4) Hornigold, Rachael E a Golding, John F b Ferner, Robin E c Ferner, Rosalie E a

a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST (United Kingdom)

b UNIVERSITY OF WESTMINSTER (United Kingdom)

c West Midlands Centre for Adverse Drug Reactions (United Kingdom)

Author keywords

Hypertension; Neurofibromatosis 2; Vasculopathy

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NEUROFIBROMATOSIS; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; CASE-CONTROL STUDIES; DIASTOLE; FEMALE; HUMANS; HYPERTENSION; MALE; NEUROFIBROMATOSIS 2; RISK FACTORS; SYSTOLE;

EID: 79959514654 PISSN: 15524825 EISSN: 15524833 Source Type: Journal
DOI: 10.1002/ajmg.a.34035 Document Type: Article

Times cited : (8)

References (12)

1
- 0036780708
- Predictors of the risk of mortality in neurofibromatosis 2
- Baser ME, Friedman JM, Aeschliman D, Joe H, Wallace AJ, Ramsden RT, Evans DGR. 2002. Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 71: 715-723.
- (2002) Am J Hum Genet , vol.71 , pp. 715-723
- Baser, M.E.¹ Friedman, J.M.² Aeschliman, D.³ Joe, H.⁴ Wallace, A.J.⁵ Ramsden, R.T.⁶ Evans, D.G.R.⁷

2
- 0028980081
- Widespread but cell type specific expression of the mouse neurofibromatosis type 2 gene
- Claudio JO, Lutchman M, Rouleaur GA. 1995. Widespread but cell type specific expression of the mouse neurofibromatosis type 2 gene. Neuro Report 6: 1942-1946.
- (1995) Neuro Report , vol.6 , pp. 1942-1946
- Claudio, J.O.¹ Lutchman, M.² Rouleaur, G.A.³

3
- 31144458999
- Renal vascular disease in neurofibromatosis type 2: Association or coincidence?
- Cordeiro NJ, Gardner KR, Huson SM, Stewart H, Elston JS, Howard EL, Tullus KO, Pike MG. 2006. Renal vascular disease in neurofibromatosis type 2: Association or coincidence? Dev Med Child Neurol 48: 58-59.
- (2006) Dev Med Child Neurol , vol.48 , pp. 58-59
- Cordeiro, N.J.¹ Gardner, K.R.² Huson, S.M.³ Stewart, H.⁴ Elston, J.S.⁵ Howard, E.L.⁶ Tullus, K.O.⁷ Pike, M.G.⁸

4
- 12344281996
- Incidence of vestibular schwannoma and neurofibromatosis 2 in the north west of England over a 10-year period: Higher incidence than previously thought
- Evans DGR, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R. 2005. Incidence of vestibular schwannoma and neurofibromatosis 2 in the north west of England over a 10-year period: Higher incidence than previously thought. Otol Neurotol 26: 93-97.
- (2005) Otol Neurotol , vol.26 , pp. 93-97
- Evans, D.G.R.¹ Moran, A.² King, A.³ Saeed, S.⁴ Gurusinghe, N.⁵ Ramsden, R.⁶

5
- 33847680538
- Neurofibromatosis 1 and neurofibromatosis 2: A 21st century perspective
- Ferner RE. 2007. Neurofibromatosis 1 and neurofibromatosis 2: A 21st century perspective. Lancet Neurol 6: 340-351.
- (2007) Lancet Neurol , vol.6 , pp. 340-351
- Ferner, R.E.¹

6
- 0037137896
- Histone deacetylase inhibitor FK228 inhibits tumour angiogenesis
- Kwon HJ, Kim MJ, Nakajima H, Kim KW. 2002. Histone deacetylase inhibitor FK228 inhibits tumour angiogenesis. Int J cancer 97: 290-296.
- (2002) Int J cancer , vol.97 , pp. 290-296
- Kwon, H.J.¹ Kim, M.J.² Nakajima, H.³ Kim, K.W.⁴

7
- 16544374716
- N-butylcyanoacrylate embolization of a middle meningeal artery aneurysm in a patient with neurofibromatosis type 2
- Lesley WS, Thomas MR, Abdulrauf SI. 2004. N-butylcyanoacrylate embolization of a middle meningeal artery aneurysm in a patient with neurofibromatosis type 2. AJNR 25: 1414-1416.
- (2004) AJNR , vol.25 , pp. 1414-1416
- Lesley, W.S.¹ Thomas, M.R.² Abdulrauf, S.I.³

8
- 75749140889
- Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
- Mautner VF, Nguyen R, Kutta H, Fuensterer C, Bokemeyer C, Hagel C, Reinhard EF, Panse J. 2010. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro-Oncology 12: 14-18.
- (2010) Neuro-Oncology , vol.12 , pp. 14-18
- Mautner, V.F.¹ Nguyen, R.² Kutta, H.³ Fuensterer, C.⁴ Bokemeyer, C.⁵ Hagel, C.⁶ Reinhard, E.F.⁷ Panse, J.⁸

9
- 77956129095
- Cardiac side-effects of cancer chemotherapy
- Monsuez JJ, Charnior JC, Vignat N, Artigou JY. 2010. Cardiac side-effects of cancer chemotherapy. Int J Cardiol 144: 3-15.
- (2010) Int J Cardiol , vol.144 , pp. 3-15
- Monsuez, J.J.¹ Charnior, J.C.² Vignat, N.³ Artigou, J.Y.⁴

10
- 57449091773
- Stroke in a child with neurofibromatosis type 2
- Ng J, Mordekar SR, Connolly DJA, Baxter P. 2009. Stroke in a child with neurofibromatosis type 2. Europ J Paediatr Neurol 13: 77-79.
- (2009) Europ J Paediatr Neurol , vol.13 , pp. 77-79
- Ng, J.¹ Mordekar, S.R.² Connolly, D.J.A.³ Baxter, P.⁴

11
- 67651173054
- Hearing improvement after bevacizumab in patients with neurofibromatosis type 2
- Plotkin SR, Stemmer-Rachamimov AO, Barker FG, Halpin C, Padera TP, Tyrrell A, Sorenson AG, Jain RK, di Tomaso E. 2009. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. NEJM 361: 358-367.
- (2009) NEJM , vol.361 , pp. 358-367
- Plotkin, S.R.¹ Stemmer-Rachamimov, A.O.² Barker, F.G.³ Halpin, C.⁴ Padera, T.P.⁵ Tyrrell, A.⁶ Sorenson, A.G.⁷ Jain, R.K.⁸ di Tomaso, E.⁹

12
- 22044440484
- Vascular dysplasia in neurofibromatosis type 2
- Ryan AM, Hurley M, Brennan P, Moroney JT. 2005. Vascular dysplasia in neurofibromatosis type 2. Neurology 12: 163-164.
- (2005) Neurology , vol.12 , pp. 163-164
- Ryan, A.M.¹ Hurley, M.² Brennan, P.³ Moroney, J.T.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.